<DOC>
	<DOCNO>NCT01284036</DOCNO>
	<brief_summary>The purpose study find safety side effect investigational drug healthy volunteer . See quickly investigational drug enters bloodstream , distribute body , broken remove healthy male female volunteer . See body make antibody investigational drug ( immune system respond ) .</brief_summary>
	<brief_title>A Single Dose Study Of The Safety And Investigational Product Level Measurement In Healthy Subjects</brief_title>
	<detailed_description>First human study collect safety pharmacokinetics ( PK ) single ascend dose Healthy subject</detailed_description>
	<criteria>Healthy male and/or female subject age 18 55 year . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . Treatment investigational drug within 30 day ( determined local requirement , whichever long ) 5 halflives precede first dose study medication . Receipt treatment investigational market biologic drug . blood donation approximately 1 pint ( 500 mL ) within 56 day prior dose .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Healthy subject</keyword>
	<keyword>safety</keyword>
	<keyword>PK study</keyword>
	<keyword>healthy volunteer</keyword>
</DOC>